The Department of Bioengineering at the UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system enables functional treatment imaging of diseases throughout the whole-body of a small animal while providing at the same time critical tissue characterization information.
Bioengineering Department of UT Dallas
According to Prof. Kenneth Hoyt, Director of the Small Animal Imaging Core facility:
The combination of 3D optical imaging with ultra-high-resolution microCT expands applications beyond traditional optical imaging. For instance, this Hybrid OI/CT system enables to pinpoint cancer deep into tissue and at the same time, can provide distinctive microvascular characteristics such as blood supply to determine whether tumors are prone to growth and metastasis. This provides prognostic value when monitoring early tumor response to neoadjuvant treatment.”
Prof. Frederik Beekman, CEO/CSO of MILabs adds:
We are excited that Prof. Hoyt’s team, a trend-setter in the disease and treatment effects of microvascular dysfunction, has selected Hybrid 3D OI/CT for his innovative research work. We hope to further collaborate with UT Dallas on future translational research by expanding his system with nuclear imaging capabilities such as PET and SPECT”